Electrolyte Balance Effects of Sterofundin Versus Normal Saline in Diabetic Ketoacidosis
NCT ID: NCT06399510
Last Updated: 2024-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
58 participants
INTERVENTIONAL
2024-03-01
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
i. Is there any difference in duration of bicarbonate (HCO3-) to reach equal or more than 15mmol/L from the initial blood taking in between Sterofundin and NS fluid use in DKA patients? ii. Is there any difference in the level of post-infusion serum sodium (Na+) between Sterofundin and NS fluid use in DKA patients? iii. Is there any difference in the level of post-infusion serum potassium (K+) between Sterofundin and NS fluid use in DKA patients?
Patients will be randomized in a 1:1 ratio to receive IV Sterofundin (intervention) or IV Normal Saline (standard care). The patient will have the respective fluid regime as the main fluid therapy during the first 24 hours of ICU stay. If patients were randomized to the control arm, the fluid regime for the first 24 hours in ICU will be normal saline. If patients were randomized to the interventional arm, the main fluid therapy during the first 24 hours of ICU stay will be Sterofundin.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis
NCT05752279
0.9% Saline Versus Balanced Solutions in Severe Diabetic Ketoacidosis
NCT05808972
Comparison of an Isotonic Balanced Fluid, SterofundinĀ® , With 0.9% Saline in Traumatic Brain Injury(TBI)
NCT02866604
Change in Serum Chloride Level After Loading Dose of Sterofundin Solution Compared With Normal Saline Solution
NCT02950974
Normal Saline Versus Balance Salt Solution Resuscitation on Kidney Function
NCT02520804
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal Saline
If patients were randomized to the control arm, the fluid regime for the first 24 hours in ICU will be normal saline.
Sterofundin fluid therapy
Sterofundin is known as balanced solution which has similar electrolytes content as per human plasma.
Sterofundin
If patients were randomized to the interventional arm, the main fluid therapy during the first 24 hours of ICU stay will be Sterofundin.
Sterofundin fluid therapy
Sterofundin is known as balanced solution which has similar electrolytes content as per human plasma.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sterofundin fluid therapy
Sterofundin is known as balanced solution which has similar electrolytes content as per human plasma.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged ā„ 18 years old.
* Patients admitted to ICU \< 12 hours after initial fluid resuscitation from emergency department/ ward.
Exclusion Criteria
* Heart failure
* Started treatment of sodium bicarbonate infusion prior to ICU admission
* Known allergy to Sterofundin
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universiti Sains Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohd Zulfakar Mazlan, MBBS
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universiti Sains Malaysia
Kubang Kerian, Kelantan, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
USM/JEPeM/KK/23100751
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.